image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 509.36
-0.0255 %
$ 183 B
Market Cap
74.8
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one ISRG stock under the worst case scenario is HIDDEN Compared to the current market price of 509 USD, Intuitive Surgical, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one ISRG stock under the base case scenario is HIDDEN Compared to the current market price of 509 USD, Intuitive Surgical, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one ISRG stock under the best case scenario is HIDDEN Compared to the current market price of 509 USD, Intuitive Surgical, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ISRG

image
$620.0$620.0$600.0$600.0$580.0$580.0$560.0$560.0$540.0$540.0$520.0$520.0$500.0$500.0$480.0$480.0$460.0$460.0$440.0$440.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
8.35 B REVENUE
17.24%
2.35 B OPERATING INCOME
32.95%
2.34 B NET INCOME
28.62%
2.42 B OPERATING CASH FLOW
33.15%
-3.27 B INVESTING CASH FLOW
-808.86%
151 M FINANCING CASH FLOW
152.47%
2.25 B REVENUE
-6.63%
578 M OPERATING INCOME
-21.34%
704 M NET INCOME
2.28%
582 M OPERATING CASH FLOW
-29.30%
214 M INVESTING CASH FLOW
116.89%
-236 M FINANCING CASH FLOW
-477.33%
Balance Sheet Intuitive Surgical, Inc.
image
Current Assets 7.11 B
Cash & Short-Term Investments 4.01 B
Receivables 1.36 B
Other Current Assets 1.74 B
Non-Current Assets 11.6 B
Long-Term Investments 4.9 B
PP&E 4.78 B
Other Non-Current Assets 1.95 B
21.41 %7.24 %9.29 %26.16 %25.52 %10.38 %Total Assets$18.7b
Current Liabilities 1.75 B
Accounts Payable 193 M
Short-Term Debt 33.5 M
Other Current Liabilities 1.52 B
Non-Current Liabilities 468 M
Long-Term Debt 112 M
Other Non-Current Liabilities 356 M
8.74 %68.59 %5.08 %16.07 %Total Liabilities$2.2b
EFFICIENCY
Earnings Waterfall Intuitive Surgical, Inc.
image
Revenue 8.35 B
Cost Of Revenue 2.72 B
Gross Profit 5.63 B
Operating Expenses 3.29 B
Operating Income 2.35 B
Other Expenses 11.4 M
Net Income 2.34 B
9b9b8b8b7b7b6b6b5b5b4b4b3b3b2b2b1b1b008b(3b)6b(3b)2b(11m)2bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
67.46% GROSS MARGIN
67.46%
28.12% OPERATING MARGIN
28.12%
27.81% NET MARGIN
27.81%
14.13% ROE
14.13%
12.39% ROA
12.39%
12.06% ROIC
12.06%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Intuitive Surgical, Inc.
image
2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 2.34 B
Depreciation & Amortization 462 M
Capital Expenditures -1.11 B
Stock-Based Compensation 677 M
Change in Working Capital -919 M
Others 300 K
Free Cash Flow 1.3 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Intuitive Surgical, Inc.
image
Wall Street analysts predict an average 1-year price target for ISRG of $537 , with forecasts ranging from a low of $410 to a high of $650 .
ISRG Lowest Price Target Wall Street Target
410 USD -19.51%
ISRG Average Price Target Wall Street Target
537 USD 5.40%
ISRG Highest Price Target Wall Street Target
650 USD 27.61%
Price
Max Price Target
Min Price Target
Average Price Target
650650600600550550500500450450400400Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 14
6. Ownership
Insider Ownership Intuitive Surgical, Inc.
image
Sold
0-3 MONTHS
6.47 M USD 7
3-6 MONTHS
31.7 M USD 10
6-9 MONTHS
30.6 M USD 6
9-12 MONTHS
28.9 M USD 8
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars? Over the past several years, one of the most impressive stocks in the healthcare sector has undeniably been Intuitive Surgical NASDAQ: ISRG. The company's robotics-assisted surgical devices have proven to be extremely innovative, attracting intense demand from doctors around the globe. marketbeat.com - 6 days ago
ISRG vs BSX: Which Medical Device Stock Has More Room to Run? Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds. zacks.com - 1 week ago
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $512.11, marking a -1.34% move from the previous day. zacks.com - 1 week ago
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains. zacks.com - 1 week ago
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $522.41, marking a -1.36% move from the previous day. zacks.com - 2 weeks ago
ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong Intuitive Surgical trims margin outlook on tariff headwinds, but strong procedure growth and financial resilience bolster its long-term case. zacks.com - 2 weeks ago
Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead Intuitive Surgical ISRG is currently in Phase 17 of its 18-Phase Adhishthana Cycle. While the recent correction may be causing concern among investors, from the perspective of Adhishthana Principles, the pullback appears not only expected but also healthy. benzinga.com - 2 weeks ago
Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views? When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? zacks.com - 2 weeks ago
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now? Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. zacks.com - 2 weeks ago
3 Monster Stocks -- including Nvidia -- to Hold for the Next 10 Years The S&P 500 index tracks the stock performance of America's biggest companies, and it has averaged annual gains of roughly 10% over multiple decades. That's pretty darn good performance, enough to more than quintuple an investment over 15 years for those who purchased exchange-traded funds (ETFs) mirroring the index. fool.com - 2 weeks ago
Why Intuitive Surgical Stock Plunged Today Intuitive Surgical (ISRG -5.55%), the maker of surgical robots and tools for robotic surgery, is taking it on the chin in afternoon trading Monday. Through 2:22 p.m. fool.com - 2 weeks ago
Intuitive Surgical stock dubbed a ‘premier, high-growth' name despite first sell rating Intuitive Surgical Inc. (NASDAQ: ISRG) is deep in the red this morning after Deutsche Bank issued a bearish note on the biotechnology giant based out of Sunnyvale, California. invezz.com - 2 weeks ago
8. Profile Summary

Intuitive Surgical, Inc. ISRG

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 183 B
Dividend Yield 0.00%
Description Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Contact 1020 Kifer Road, Sunnyvale, CA, 94086-5304 https://www.intuitive.com
IPO Date June 16, 2000
Employees 15638
Officers Dr. Gary S. Guthart Ph.D. Chief Executive Officer & Director Mr. Milind Wagle Chief Information Officer Mr. Brian King Vice President, Treasurer & Head of Investor Relations Mr. Gary H. Loeb J.D. Executive Vice President and Chief Legal & Compliance Officer Dr. Christopher R. Carlson Ph.D. Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures Dr. Brian E. Miller Ph.D. Executive Vice President & Chief Digital Officer Mr. Fredrik Widman Vice President, Principal Accounting Officer & Corporate Controller Mr. David J. Rosa President & Director Mr. Jamie E. Samath Executive Vice President, Chief Financial Officer and Head of Business Technology Mr. Henry L. Charlton Executive Vice President and Chief Commercial & Marketing Officer